Robeco Institutional Asset Management B.V. Decreases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Robeco Institutional Asset Management B.V. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 35.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,102 shares of the biotechnology company's stock after selling 33,577 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.08% of Axon Enterprise worth $24,816,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. TrueWealth Advisors LLC raised its holdings in shares of Axon Enterprise by 16.6% in the 3rd quarter. TrueWealth Advisors LLC now owns 1,037 shares of the biotechnology company's stock worth $414,000 after purchasing an additional 148 shares during the period. Emerald Advisers LLC increased its position in Axon Enterprise by 59.2% in the third quarter. Emerald Advisers LLC now owns 1,444 shares of the biotechnology company's stock worth $577,000 after buying an additional 537 shares during the last quarter. Realta Investment Advisors raised its stake in shares of Axon Enterprise by 23.2% in the third quarter. Realta Investment Advisors now owns 1,844 shares of the biotechnology company's stock valued at $808,000 after buying an additional 347 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Axon Enterprise by 19.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 875 shares of the biotechnology company's stock valued at $350,000 after buying an additional 142 shares during the last quarter. Finally, Gladstone Institutional Advisory LLC grew its stake in shares of Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock worth $656,000 after acquiring an additional 26 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Axon Enterprise stock traded up $18.43 during mid-day trading on Wednesday, hitting $459.52. 723,956 shares of the company traded hands, compared to its average volume of 521,086. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a one year low of $212.88 and a one year high of $462.64. The stock has a market cap of $34.73 billion, a price-to-earnings ratio of 116.38, a price-to-earnings-growth ratio of 10.99 and a beta of 0.94. The stock has a fifty day moving average price of $405.32 and a 200-day moving average price of $343.13.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same period in the previous year, the business earned $0.80 earnings per share. The firm's quarterly revenue was up 34.5% compared to the same quarter last year. On average, equities analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 25,811 shares of the firm's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares of the company's stock, valued at approximately $82,103,253.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the company's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now owns 228,166 shares in the company, valued at approximately $82,103,253.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 371,172 shares of company stock worth $137,000,162. 5.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms have commented on AXON. Bank of America initiated coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a "buy" rating and a $380.00 price objective on the stock. Craig Hallum upped their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. Robert W. Baird raised their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a report on Monday. Northland Securities boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a report on Thursday, August 8th. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $392.85.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.